H2020Докторантска мрежа2021–2025

EYE · European Young Eye

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2021-01-01 → 2025-03-31
Финансиране от ЕС
1 280 423 €
Участници
3
Схема
MSCA-ITN

Линиите свързват координатора с партньорите.

Накратко на български

Пресбиопията (възрастовата загуба на фокус при близко гледане) се изследва чрез създаването на персонализирани контактни лещи и инструменти за проследяване на състоянието. Това помага за подобряване на качеството на живот и визуалната независимост на хората с настъпваща старост.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

European Young Eye

What is the problem/issue being addressed? Presbyopia, the gradual loss of the eye's ability to focus on close objects, typically begins around the age of 40 and affects nearly everyone as they age. With increasing life expectancy, it is estimated that over a billion adults are currently living with presbyopia, which significantly impacts their daily activities and quality of life. Despite various treatments, presbyopia continues to challenge individuals, creating a need for innovative solutions that improve comfort, convenience, and effectiveness. Why is it important for society? Presbyopia affects millions globally, leading to social and economic consequences. As populations age, the prevalence of presbyopia rises, reducing productivity and increasing healthcare costs. Addressing this issue is crucial not only for improving individual quality of life but also for supporting active aging, reducing dependency, and improving visual independence. The development of better therapeutic solutions will also have a significant impact on reducing the burden on healthcare systems. What are the overall objectives? The EYE project seeks to advance scientific knowledge in vision science to develop more effective and personalized presbyopia treatments. The objectives include creating new contact lenses tailored to individual needs, enhancing lens comfort and performance, and developing technological tools to monitor and personalize patient care. The project is organized into two work packages: WP1 focuses on contact lens development, and WP2 aims to create tools for continuous monitoring outside clinical settings. The overall goal is to improve the quality of life for presbyopic patients and further the global understanding of presbyopia treatment. As part of translational objectives, the project aimed to train five Early-Stage Researchers through high-level academic and industrial exposure. This included: (i) scientific and technical training; (ii) complementary skills development; (iii) close collaboration with the private sector to bridge academic and industrial research; and (iv) structured support for career development and international networking. A further objective was to enhance the impact and visibility of EU-funded research by promoting dissemination, public engagement, and sustainable academic–industry collaboration.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

EYE project will advance the scientific knowledge in order to develop new therapeutic solutions for presbyopia. The consortium is formed by a highly inter-disciplinary team involving optometrists, chemists, biochemists, physicists, and computer engineers who have been successfully studying the different properties of the contact lenses (CLs) and presbyopia for many years. The consortium of this EID project comprises two Beneficiaries - a private sector partner – CL manufacturer (Mark’ennovy) and a university delivering PhD degrees - Universidad Complutense de Madrid (UCM). Alain Afflelou, optical centres group with more than 1.400 optical centres around the world, collaborates with EYE consortium as a Partner Organization providing access to the end users and clinicians (optometrists). The ambitious objectives of the project are: 1. To train 5 early-stage researchers (ESRs), and more specifically provide them with (i) training in state-of-the-art concepts and leading-edge research techniques essential to study the human eye’s behaviour, (ii) extensive training in complementary skills (iii) 18 months working experience in the private sector, (iv) solid professional connections for future career development. 2. To advance the scientific knowledge in the Vision Science field in order to develop more satisfying presbyopic therapeutic solutions which will positively impact the quality of the life of the patients. 3. To boost the impact and the international visibility of the European research and EU funding through the dissemination, communication and exploitation activities incorporated within the project, as well as by establishment of a long-term synergic collaboration among an academic and private sectors.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз